Skip to main content
Log in

Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

We present an interesting case with a central mediastinal pheochromocytoma showing intense F-18 fluorodeoxyglucose (FDG) uptake in tumor and systemic brown adipose tissue (BAT) mimicking metastases. The findings of hypertension and high plasma catecholamine concentration suggested the presence of pheochromocytoma. Mediastinal tumor showed intense FDG uptake and faint uptake of I-131 metaiodobenzylguanidine. Intense FDG uptake was demonstrated in cervical, paravertebral, mediastinal, and perirenal regions. Positron emission tomography and computed tomography (PET/CT) revealed uptake in a fat density area suggesting that the FDG uptake had occurred in BAT. The mediastinal tumor was resected along with an adhesion to the left atrial wall and pathologically confirmed as pheochromocytoma. The plasma catecholamine concentration and blood pressure then reverted to normal. The FDG uptake in BAT disappeared after tumor resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186:711–715.

    PubMed  CAS  Google Scholar 

  2. Maurea S, Mainolfi C, Wang H, Varrella P, Panico MR, Klain M, et al. Positron emission tomography (PET) with F-18-fluorodeoxyglucose in the study of adrenal masses: comparison of benign and malignant lesions. Radiol Med (Torino) 1996;92:782–787.

    CAS  Google Scholar 

  3. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002;29:1393–1398.

    Article  PubMed  Google Scholar 

  4. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT. J Nucl Med 2003;44:170–176.

    PubMed  CAS  Google Scholar 

  5. Fukuchi K, Tatsumi M, Ishida Y, Oku N, Hatazawa J, Wahl RL. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp Clin Endocrinol Diabetes 2004;112:601–603.

    Article  PubMed  CAS  Google Scholar 

  6. English JT, Patel SK, Flanagan MJ. Association of pheochromocytomas with brown fat tumors. Radiology 1973;107:279–281.

    PubMed  CAS  Google Scholar 

  7. Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue in patients with phaeochromocytoma. Int J Obes 1986;10:219–227.

    PubMed  CAS  Google Scholar 

  8. Elsayes KM, Narra VR, Leyendecker JR, Francis IR, Lewis JS Jr, Brown JJ. MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol 2005;184:860–867.

    PubMed  Google Scholar 

  9. Kopf D, Bockisch A, Steinert H, Hahn K, Beyer J, Neumann HP, et al. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol (Oxf) 1997;46:39–44.

    Article  CAS  Google Scholar 

  10. Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta 3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 2004;145:269–280.

    Article  PubMed  CAS  Google Scholar 

  11. Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL. Intense 18F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 2004;45:1189–1193.

    PubMed  CAS  Google Scholar 

  12. Soderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging 2007;34:1018–1022.

    Article  PubMed  Google Scholar 

  13. Menzel C, Graichen S, Berner U, Risse JH, Diehl M, Dobert N, et al. Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET. Acta Med Austriaca 2003;30:37–40.

    Article  PubMed  CAS  Google Scholar 

  14. Ezuddin S, Fragkaki C. MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy. Clin Nucl Med 2005;30:579–581.

    Article  PubMed  Google Scholar 

  15. Glodny B, Winde G, Herwig R, Meier A, Kuhle C, Cromme S, et al. Clinical differences between benign and malignant pheochromocytomas. Endocr J 2001;48:151–159.

    Article  PubMed  CAS  Google Scholar 

  16. Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol 2002;13:149–156.

    Article  PubMed  Google Scholar 

  17. Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, et al. Adrenal masses: MR imaging features with pathologic correlation. Radiographics 2004;24Suppl 1:S73–S86.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ichiei Kuji.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuji, I., Imabayashi, E., Minagawa, A. et al. Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma. Ann Nucl Med 22, 231–235 (2008). https://doi.org/10.1007/s12149-007-0096-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0096-x

Keywords

Navigation